Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286078 · ClinicalTrials.gov registry record · NA
Treatment for Migraines With an Implantable Device
A NA study of Migraine, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
- 15
- Study locations
NCT00286078: Completed NA study of Migraine, sponsored by Boston Scientific Corporation.
NCT00286078 is a NA study of Migraine that has completed, run by Boston Scientific Corporation. The registered enrollment target is 179 participants, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (50% lower). The trial reports 15 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00286078, a NA study of Migraine, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
Primary Outcome
Change from baseline in migraine days/month at 12 weeks
Conditions Studied
Interventions
- DEVICE Precision
Study Locations (15)
Illinois
- Rush Pain Center - Chicago
- Diamond Headache Clinic - Chicago
Colorado
- Mile High Research Center - Denver
Connecticut
- The New England Center for Headache - Stamford
Georgia
- Walton Rehabilitation Hospital - Augusta
Massachusetts
- New England Regional Headache Center - Worcester
Missouri
- Headache Care Center - Springfield
Nevada
- Headache Specialists - Las Vegas
New York
- Albert Einstein College of Medicine - Montefiore Headache Unit - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2006-02 |
| Est. Completion | 2018-11-07 |
| Phase | NA |
What the finished NCT00286078 record still lists
NCT00286078 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 356-participant average among 102 other Migraine trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Precision is the first listed.
NCT00286078 lists 15 locations in 14 states (Illinois, Colorado, Connecticut).
Frequently Asked Questions
What is clinical trial NCT00286078 about?
NCT00286078 is a clinical study titled "Treatment for Migraines With an Implantable Device". The purpose of this study is to evaluate the safety and effectiveness of an implantable device for difficult to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
What is the current status of trial NCT00286078?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2006-02. Estimated completion is 2018-11-07.
What conditions does trial NCT00286078 study?
This clinical trial studies the following conditions: Migraine.
What interventions are being tested in trial NCT00286078?
The interventions under investigation include: Precision (DEVICE).
Who is sponsoring clinical trial NCT00286078?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00286078 being conducted?
This trial has 15 study locations across Colorado, Connecticut, Georgia, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00286078's enrollment target sits among peer trials
179 44th of 102 higher than 59 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia